• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Occlusion (1984); Perforation (2001)
Event Date 01/01/2020
Event Type  Injury  
Manufacturer Narrative
The item number and lot number of the device could not be provided, so no manufacturing evaluation could not be performed.The device remains implanted.Therefore, direct product analysis was not possible.
 
Event Description
The following publication was reviewed: "off-the-shelf devices for treatment of thoracic aortic diseases: midterm follow-up of tevar with chimneys or physician-made fenestrations" received through "journal of endovascular therapy 2020, vol.27(1) 132¿142".The authors: lei zhang, md, phd, meng-tao wu, md, phd, guang-lang zhu, md, et al.The article aimed to evaluate the midterm outcomes of thoracic endovascular aortic repair (tevar) using chimney grafts (ch-tevar) or thoracic stent-grafts with fenestrations made on the back table (f-tevar) to treat thoracic aortic dissection (tad) and thoracic aortic aneurysm (taa).A retrospective analysis was conducted of 474 consecutive patients (mean age 62.3±10.7 years; 346 men) treated with either f-tevar (n=110) or ch-tevar (n=364) for 352 tads (81 f-tevar and 271 ch-tevar) or 122 taas (29 f-tevar and 93 ch-tevar) from 2008 to 2016.Tag was used in ch-tevar(96/364), viabahn was used in f-tevar(29/75) and in ch-tevar(260/518).The results stated one hundred (16.9%) of the 593 branch stents occluded (4/75 in the f-tevar group and 96/518 in the ch-tevar group, p<0.01).Of the 62 (13.1%) patients with branch occlusion, 28 were asymptomatic, and no reintervention was performed (7.2% branch reintervention rate).The branch reintervention rate was 7.2% (34/474).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key10498439
MDR Text Key208792215
Report Number2017233-2020-01239
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 09/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/14/2020
Initial Date FDA Received09/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62
-
-